ASHLEY LONG: Open Payments
NPI 1902470842 · LILLINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$654 in 38 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $654
Food & beverage: $654
| Company | Payments | Amount |
|---|---|---|
| SCILEX PHARMACEUTICALS INC. | 20 | $259 |
| Lundbeck LLC | 3 | $75 |
| ABBVIE INC. | 3 | $68 |
| Neurocrine BioSciences, Inc. | 3 | $67 |
| Forte Bio-Pharma LLC | 2 | $55 |
| Lilly USA, LLC | 2 | $33 |
| PFIZER INC. | 2 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $29 |
| Genentech USA, Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: ZTLido, VYEPTI, INGREZZA, PROLATE, QULIPTA, NURTEC ODT, AUSTEDO XR, Ocrevus Zunovo.
Industry payments across NC — which companies pay providers there.
